JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.
Wang X, Yang Y, Ren D, Xia Y, He W, Wu Q, Zhang J, Liu M, Du Y, Ren C, Li B, Shen J, Zhang Y.
Wang X, et al. Among authors: zhang j, zhang y.
Br J Pharmacol. 2020 Jul;177(13):2959-2973. doi: 10.1111/bph.15023. Epub 2020 Mar 23.
Br J Pharmacol. 2020.
PMID: 32060899
Free PMC article.